Mr. Tan Huidong has 20 years of experience in asset management and secondary securities market investment management.

Mr. Tan has participated in investments in projects including Kangtai Biological Products (300601), Hybribio (300639), and BGE (603588), and was responsible for on-site investment management at Hybribio, achieving solid investment performance. He also serves as a director of Enshi Technology.

Prior to co-founding Pulin Capital, Mr. Tan held investment management roles at Everbright International Trust & Investment Corporation, Everbright Securities, and Capital Futures Company, where he gained extensive experience in China's domestic capital markets, particularly in secondary market operations.

Mr. Tan graduated from East China Normal University with a Bachelor of Economics.